Teva Pharmaceutical Industries (TEVA) net assets (shareholders' equity)
Teva Pharmaceutical Industries (TEVA) had net assets of $7.91B at the end of fiscal 2025 (December 31, 2025). That is 47.2% higher than the $5.37B of fiscal 2024. Figures as of 18 Nov 2026, 19:50 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Net assets, fiscal 2025
- $7.91B
- Change on fiscal 2024
- +47.2%
- Growth, 5 years
- −4.6% a year
- Growth, 10 years
- −12.4% a year
- Highest on record
- $33.34Bfiscal 2016
- Lowest on record
- $5.37Bfiscal 2024
- Fiscal years on record
- 192007–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Teva Pharmaceutical Industries net assets (shareholders' equity), in more detail
Over the five fiscal years to 2025 net assets shrank at a compound 4.6% a year; over ten years the rate was −12.4% a year. Across the 19 fiscal years on record (2007–2025), the highest was $33.34B in fiscal 2016 and the lowest $5.37B in fiscal 2024.
Net assets by fiscal year
Teva Pharmaceutical Industries net assets (shareholders' equity), year by year
| Fiscal year | Net assets | Change | Year ended |
|---|---|---|---|
| 2025 | $7.91B | 47.2% up | |
| 2024 | $5.37B | 28.4% down | |
| 2023 | $7.51B | 3.8% down | |
| 2022 | $7.80B | 24.1% down | |
| 2021 | $10.28B | 2.5% up | |
| 2020 | $10.03B | 28.2% down | |
| 2019 | $13.97B | 5.0% down | |
| 2018 | $14.71B | 15.3% down | |
| 2017 | $17.36B | 47.9% down | |
| 2016 | $33.34B | 12.0% up | |
| 2015 | $29.77B | 27.7% up | |
| 2014 | $23.31B | 3.3% up | |
| 2013 | $22.57B | 0.9% down | |
| 2012 | $22.77B | 2.6% up | |
| 2011 | $22.20B | 1.1% up | |
| 2010 | $21.95B | 14.2% up | |
| 2009 | $19.22B | 17.4% up | |
| 2008 | $16.38B | 18.1% up | |
| 2007 | $13.86B | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.
How to read it
Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.
Net assets at health care companies of similar size
| Company | Net assets | Fiscal year |
|---|---|---|
| Medline MDLN | $10.74B | 2025 |
| Humana HUM | $17.66B | 2025 |
| Agilent Technologies A | $6.74B | 2025 |
| Teva Pharmaceutical Industries TEVA | $7.91B | 2025 |
| BeOne Medicines ONC | $4.36B | 2025 |
| Waters WAT | $2.56B | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Teva Pharmaceutical Industries, figure by figure
- Teva Pharmaceutical Industries market cap
- Teva Pharmaceutical Industries revenue
- Teva Pharmaceutical Industries earnings
- Teva Pharmaceutical Industries earnings per share (EPS)
- Teva Pharmaceutical Industries P/E ratio
- Teva Pharmaceutical Industries P/S ratio
- Teva Pharmaceutical Industries P/B ratio
- Teva Pharmaceutical Industries free cash flow
- Teva Pharmaceutical Industries operating margin
- Teva Pharmaceutical Industries dividend
- Teva Pharmaceutical Industries shares outstanding
- Teva Pharmaceutical Industries total debt
- Teva Pharmaceutical Industries cash on hand
- Teva Pharmaceutical Industries total assets
- Teva Pharmaceutical Industries total liabilities
- Teva Pharmaceutical Industries return on equity (ROE)
- Teva Pharmaceutical Industries return on invested capital (ROIC)
Teva Pharmaceutical Industries (TEVA) overview: price, valuation and scorecardAll health care companies by market value
Teva Pharmaceutical Industries net assets (shareholders' equity): questions and answers
What are Teva Pharmaceutical Industries's net assets?
Teva Pharmaceutical Industries (TEVA) had net assets of $7.91B at the end of fiscal 2025 (December 31, 2025). That is 47.2% higher than the $5.37B of fiscal 2024.
What is the growth rate of Teva Pharmaceutical Industries's net assets?
Over the five fiscal years to 2025 net assets shrank at a compound 4.6% a year; over ten years the rate was −12.4% a year.
What are the highest and lowest net assets figures on record for Teva Pharmaceutical Industries?
Across the 19 fiscal years on record (2007–2025), the highest was $33.34B in fiscal 2016 and the lowest $5.37B in fiscal 2024.
How is Teva Pharmaceutical Industries's net assets calculated?
Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Teva Pharmaceutical Industries it is on record here for 19 fiscal years, 2007 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: net assets (shareholders' equity)
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Teva Pharmaceutical Industries (TEVA) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/TEVA/net-assets
Underlying data: the company's filings with the SEC and Yahoo Finance.